As of August 29, 2026, Tarsus Pharmaceuticals's top three insider holders are Capital Ix, Llc Vivo (TenPercentOwner, 2.47Mn shares), Capital Ix, Llc Vivo (TenPercentOwner, 2.47Mn shares), Michael Ackermann (Director, 1.21Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Capital Ix, Llc Vivo | TenPercentOwner | 0 | 2,469,001 | 2,469,001 | 48.9% | 05 May, 2022 |
| 2 | Michael Ackermann | Director | 1,208,273 | 0 | 1,208,273 | 23.9% | 17 Jun, 2022 |
| 3 | Bobak R. Azamian | President/Ceo And Board Chair | 0 | 847,991 | 847,991 | 16.8% | 22 Jun, 2026 |
| 4 | William J Phd Link | Director | 106,786 | 0 | 106,786 | 2.1% | 17 Jun, 2026 |
| 5 | Seshadri Neervannan | Chief Operating Officer | 82,791 | 0 | 82,791 | 1.6% | 24 Mar, 2026 |
| 6 | Bryan Wahl | General Counsel | 63,959 | 0 | 63,959 | 1.3% | 19 Mar, 2026 |
| 7 | Aziz Mottiwala | Chief Commercial Officer | 61,480 | 0 | 61,480 | 1.2% | 19 Mar, 2026 |
| 8 | Jeffrey S Farrow | Officer | 56,801 | 0 | 56,801 | 1.1% | 17 Jun, 2026 |
| 9 | Dianne C. Whitfield | Chief Human Resources Officer | 35,028 | 0 | 35,028 | 0.7% | 19 Mar, 2026 |
| 10 | Leonard M. Greenstein | Chief Financial Officer | 26,785 | 0 | 26,785 | 0.5% | 21 Apr, 2023 |
| 11 | Elizabeth Yeu Lin | Chief Medical Officer | 23,308 | 0 | 23,308 | 0.5% | 19 Mar, 2026 |
| 12 | Andrew D. Goldberg | Director | 19,654 | 0 | 19,654 | 0.4% | 16 Jun, 2026 |
| 13 | Wendy L Yarno | Director | 16,654 | 0 | 16,654 | 0.3% | 16 Jun, 2026 |
| 14 | Bhaskar Chaudhuri | Director | 11,654 | 0 | 11,654 | 0.2% | 16 Jun, 2026 |
| 15 | Scott W Morrison | Director | 7,638 | 0 | 7,638 | 0.2% | 16 Jun, 2026 |
| 16 | Rosemary A Crane | Director | 5,350 | 0 | 5,350 | 0.1% | 25 Jun, 2024 |
| 17 | Mark J. Holdbrook | V.P., Clinical Affairs | 3,191 | 0 | 3,191 | 0.1% | 21 Mar, 2023 |
| 18 | Jose M. Trevejo | Chief Medical Officer | 2,251 | 0 | 2,251 | 0.0% | 22 Dec, 2023 |
| 19 | Katherine Goodrich | Director | 2,233 | 0 | 2,233 | 0.0% | 17 Jun, 2026 |
| 20 | David E I Pyott | Director | 1,383 | 0 | 1,383 | 0.0% | 28 Apr, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 25 Jun, 2026 | David E I Pyott | Director | Acquired A | 3,837 | $0.00 | $0 | 3,837 | Direct |
| 25 Jun, 2026 | Katherine Goodrich | Director | Acquired A | 3,837 | $0.00 | $0 | 3,837 | Direct |
| 25 Jun, 2026 | Scott W Morrison | Director | Acquired A | 3,837 | $0.00 | $0 | 3,837 | Direct |
| 25 Jun, 2026 | Bhaskar Chaudhuri | Director | Acquired A | 3,837 | $0.00 | $0 | 3,837 | Direct |
| 25 Jun, 2026 | William J Phd Link | Director | Acquired A | 3,837 | $0.00 | $0 | 3,837 | Direct |
| 25 Jun, 2026 | Andrew D. Goldberg | Director | Acquired A | 3,837 | $0.00 | $0 | 3,837 | Direct |
| 25 Jun, 2026 | Wendy L Yarno | Director | Acquired A | 3,837 | $0.00 | $0 | 3,837 | Direct |
| 25 Jun, 2026 | William J Phd Link | Director | Acquired A | 2,417 | $0.00 | $0 | 2,417 | Direct |
| 25 Jun, 2026 | Wendy L Yarno | Director | Acquired A | 2,417 | $0.00 | $0 | 2,417 | Direct |
| 25 Jun, 2026 | Scott W Morrison | Director | Acquired A | 2,417 | $0.00 | $0 | 2,417 | Direct |
| 25 Jun, 2026 | Bhaskar Chaudhuri | Director | Acquired A | 2,417 | $0.00 | $0 | 2,417 | Direct |
| 25 Jun, 2026 | Katherine Goodrich | Director | Acquired A | 2,417 | $0.00 | $0 | 2,417 | Direct |
| 25 Jun, 2026 | Andrew D. Goldberg | Director | Acquired A | 2,417 | $0.00 | $0 | 2,417 | Direct |
| 25 Jun, 2026 | David E I Pyott | Director | Acquired A | 2,417 | $0.00 | $0 | 2,417 | Direct |
| 25 Jun, 2026 | Wendy L Yarno | Director | Acquired A | 1,209 | $0.00 | $0 | 1,209 | Direct |
| 25 Jun, 2026 | William J Phd Link | Director | Acquired A | 806 | $0.00 | $0 | 806 | Direct |
| 25 Jun, 2026 | David E I Pyott | Director | Acquired A | 806 | $0.00 | $0 | 806 | Direct |
| 17 Jun, 2026 | Bobak R. Azamian | President/Ceo And Board Chair | Disposed S | 4,582 | $61.24 | $280.60K | 853,409 | Indirect |
| 17 Jun, 2026 | Bobak R. Azamian | President/Ceo And Board Chair | Disposed S | 5,418 | $61.81 | $334.89K | 847,991 | Indirect |
| 15 Jun, 2026 | William J Phd Link | Director | Disposed S | 10,572 | $61.97 | $655.15K | 108,714 | Direct |